YOUR ORAL SOLID DOSE. In pursuit of excipient excellence

Similar documents
The unlocked synergy of DFE Pharma MCC

The binding performance of DFE Pharma Starch

Primellose is an excellent choice as superdisintegrant in ODT applications

Re-compaction properties of lactose and microcrystalline cellulose

Content Uniformity of Direct Compression tablets

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

Critical material properties for the design of robust drug products : excipient functionality related characteristics

ORAL DOSAGE OVERVIEW

Direct Compression. With the right ingredients it s a simple, cost-effective manufacturing process

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

TECHNICAL INFORMATION RxCIPIENTS FM A versatile excipient for orally disintegrating tablet (ODT) formulations

Designed and manufactured specifically for pharmaceutical capsule filling

FLORITER. New Technology for Innovative Formulation Design.

Dow Wolff Cellulosics. Using ingenuity and savvy. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow

Everything for Inhalation

Formulation and Evaluation

The Particle Design of Cellulose and the Other Excipients for a Directly Compressible Filler-Binder

New formulas for successful drug delivery Hot-melt extrusion for enhanced solubility and bioavailability

SCIENTIFIC DISCUSSION. Efavirenz

SUMMARY AND CONCLUSION

AAPS Annual Meeting, San Diego, CA November 12, 2017 Short Course. Pharmaceutical Excipients: Biopharmaceutical, QC and Regulatory Considerations

SCIENTIFIC DISCUSSION. Antimycobacterial (J04AC01).

EXPANDING WHAT S POSSIBLE WITH THE RIGHT PARTNER. Life-saving pharmaceuticals start with high-quality ingredients

SCIENTIFIC DISCUSSION

Review Article ISSN: Open Access. Regulatory Aspects of Pharmaceutical Excipients in India and their Qualification to Use in Pharmaceuticals

Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good

innovative products. faster to market. reliably supplied.

FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels

Technical brochure StarLac

innovative products. faster to market. reliably supplied.

Ingredients adapted to a fit for use model. APIs allowed the fit for use strategy to work. There has been a shift to designed for purpose

Co-Processed Excipients: Regulatory Challenges. Carl Mroz Colorcon Limited June 2009

The solid choice for Omega-3

Scopus. Cancer Research and Treatment Activity Report

Your ideal partner in benefiting patient health worldwide. Pharmaceutical Solutions 2018

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence

ADVANCIA : A TRUE PLATFORM & INNOVATIVE SYSTEM OFFERING EFFICIENT NASAL DOSE DELIVERY

OCE TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE. Technical brochure MicroceLac 100

Excipient Quality & Trouble Shooting. By Seema Trivedi GM, Technical

Formulation and evaluation of oro-dispersible tablets of lafutidine

REGULATORY PERSPECTIVE. Dr. Raghunandan H V Associate Professor JSSCP, JSSU, Mysore

PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM

Location of HENGRUI. The Headquarters: No.7 Kunlunshan Road, Economic & Technological Development Zone Lianyungang, Jiangsu, China

The Wright Grou. the history of

Animal Health. Premixes Dietary Fibers. and Gels Solid. Dosage Forms. Liquids. Product Overview. Customize Your Formulation

3. Drug or plant or excipients profile

Lactose Free, Direct Compression Formulation Used to Produce Loratadine (10 mg) Tablets

Rationale of and Experience with the Expert System

Excipient Functionality & Pharmacopoeia IPEC Europe Excipients Forum Nice, 5 February 2015

Technical brochure CombiLac

Advanced functional coating solutions for nutraceuticals

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

Portico Transcatheter Aortic Valve Implantation System. portico PRECISION

The Future of Co-processed Excipients

Boehringer Ingelheim Biopharmaceuticals in China. Your Reliable Contract Manufacturing Solution Provider

Nutrition Improvement Program. NutriRice hot extrusion technology a breakthrough in rice fortification

Soluplus The Solid Solution Opening New Doors in Solubilization.

Formulation and Evaluation of Rosuvastatin Immediate Release Tablets 10 Mg

Wherever life takes you BASF excipients for orally disintegrating tablets make medication easy

TEPZZ _7584 A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/00 ( ) A61K 31/439 (2006.

Partner with the Global Leader in Drug Delivery Systems

The influence of lactose particle size on dry powder inhalation performance

Expert support to create delicious savory foods

A HIGHER DEGREE OF CONFIDENCE

SCIENTIFIC DISCUSSION

CONTENTS PAGE. Please note: Preface Matrix system Selection of METOLOSE grades Specifications

AstraZeneca and Daiichi Sankyo Launch Proton Pump Inhibitor Nexium 10 mg and 20 mg Granules for Suspension, Sachet, in Japan

GLYCOLYS

Easy, fast and reliable!

STARCH Application Data

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

E11(R1) Addendum to E11: Clinical Investigation of Medicinal Products in the Pediatric Population Step4

CAPMUL + CAPTEX + ACCONON = SEDDS

ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE

ZEODENT. High performing dental silicas. Engineered to Deliver Exceptional Performance and Formulating Flexibility

sports nutrition seminar

AUSTRALIAN MADE CAMPAIGN LIMITED

Dissolution control of direct compression tablets in different test media using novel pregelatinized starch, Swelstar TM MX-1

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

Technical brochure InhaLac

Direct Compression Formulation Using Starch 1500 with Ranitidine HCl (150 mg) Tablets, Film Coated with Opadry II (85F Series)

Anti-epilepsy Drug VIMPAT for I.V. infusion 200mg Launched in Japan

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Partner with the Global Leader in Drug Delivery Systems.

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

Nutrition. Beauty & Vitality designers. Ingredients that inspire

Bioequivalence Requirements: USA and EU

EP B1 (19) (11) EP B1 (12) EUROPEAN PATENT SPECIFICATION

CONCEPT ALLIED. Allied became reality when Industrial Experts thought of coming together to fructify business ideas!!!

Assessment of Low Dose Content Uniformity of Indomethacin in Excipient Blends Using FT-Raman Mapping Spectroscopy

Librel. Highly soluble chelates for plant nutrition

STUDY OF THE DETERIORATION OF ASPIRIN IN THE PRESENCE OF VARIOUS EXCIPIENTS

ARBOCEL. Natural Raw Fibre Concentrates. Innovative Raw Fibre Concentrates for successful petfood products. J. RETTENMAIER & SÖHNE Fibres designed

Nutrition. Beauty & Vitality designers. Ingredients that inspire

Ciprofloxacin Bluefish (Ciprofloxacin hydrochloride)

Advanced functional coating solutions for nutraceuticals

Converting between PDEs and Concentration Limits

REFERENCE CODE GDHC294DFR PUBLICATION DATE NOVEMBER 2013 PROTOPIC (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022

Taking Health & Nutrition to the NEXT Level

Transcription:

YOUR ORAL SOLID DOSE DFE Pharma globally supplies a unique, broad portfolio of key excipients including lactose, MCC, superdisintegrants and starches. Innovative products such as SuperTab 24AN and SuperTab 40LL are supported by highly appreciated, local technical support. Contact DFE Pharma for your Oral Solid Dose. In pursuit of excipient excellence

We are DFE Pharma We are DFE Pharma: the global leader in excipient solutions. We develop, produce and supply excipients for use in oral solid dose and inhalation formulations, but as a supplier of complete solutions we do a lot more than that. We work closely with pharmaceutical companies around the world, collaborating in original research, supporting their go to market strategies and fine-tuning our products to ensure that their medicines deliver exactly the right outcomes for patients. That makes us more than just a supplier. We are recognised as a true partner to the pharmaceutical industry in helping people around the world lead healthier lives. Our customers respect us for product quality, technical expertise and hands-on market support. We work with your future in mind: today, tomorrow and always. Our portfolio consists of filler/ binders (Lactose, Micro crystalline Cellulose, Starches) and superdisintegrants (Croscarmellose Sodium and Sodium Starch Glycolate) for oral solid dose, as well as carriers for inhalation (Lactose). DFE Pharma, in pursuit of excipient excellence. We have spent more than 100 years in proving that excellence is not just a word but a deep, longterm commitment to our customers and to the millions of patients who use our products every day.

Your Oral Solid Dose by DFE Pharma We believe that we contribute to our customers success by providing market driven solutions which enhance their effectiveness and efficiency. Everything we do aims to contribute to these two aspects in the daily lives of our customers. Pharmaceutical excipients are used in many ways to produce tablets, capsules, inhaled products, injectables, and sachets. All with their different demands. Tablets, capsules, and sachets are the most common Oral Solid Dosage Forms and commonly produced by: Wet Dry Direct compression Roller compaction Continuous manufacturing DFE Pharma offers a range of filler binders and disintegrants for all applications. Regulatory support At DFE Pharma we look to support our customers in efficiently navigating the regulatory space. With pharma focus and over 100 years of expertise in our excipients we provide support on a number of levels including: US & Chinese DMFs, test methodologies, guidance on IIDs, UNII, ICHQ3D and QbD. Our most commonly requested documents are freely accessable through our website www.dfepharma.com. Consistency Pharmaceutical companies and regulatory bodies have a continuous drive to develop more robust pharmaceutical formulations and processes based upon knowledge. At DFE Pharma we help de-risk the use of our excipients, in line with QbD (ICH Q8/9), by: creating batch-to-batch consistent and reproducible products providing insights in FRC s (EP) and/or CMA s (USP). Variation / changes in excipients physicalchemical & functional properties might have an impact on the performance of the final dosage form. Consistent functional excipients with a low batch-to-batch variability are minimizing the risk of failure in a worldwide setting. At DFE Pharma we utilize our history in making excipients to help our customers in their risk assessments during their QbD process. Primarily by making consistent and reproducible functional excipients thereby de-risk their use. Additionally, we assist customers in assessing our functional excipients by providing annually updated documentation exhibiting consistency of FRC s / CMA s. Upon request, it is also possible to provide multi-variant insights into the robustness of your formulation design space with regard to use of our excipients.

Overview of all DFE Pharma OSD grades Grade Lactose Pharmatose 50M Pharmatose 60M Pharmatose 70M Pharmatose 80M Pharmatose 90M Pharmatose 100M Pharmatose 110M Pharmatose 125M Lactochem Coarse Crystals Lactochem Crystals Tablets Capsules Sachets Spheres Direct compression Lactochem Coarse Powder Lactochem Regular Powder Pharmatose 130M Pharmatose 150M Pharmatose 200M Pharmatose 350M Pharmatose 450M Lactochem Coarse Powder Lactochem Regular Powder Lactochem Powder Lactochem Fine Powder Lactochem Extra Fine Powder Lactochem Super Fine Powder SuperTab 11SD SuperTab 14SD Lactopress Spray Dried Lactopress Spray Dried 250 Wet SuperTab 21AN SuperTab 22AN SuperTab 24AN Lactopress Anhydrous Lactopress Anhydrous Powder Lactopress Anhydrous Fine Powder SuperTab 30GR Lactopress Granulated SuperTab 40LL SuperTab 50ODT Lactochem Regular Powder Low Endotoxin Dry

Overview of all DFE Pharma OSD grades Grade MCC Pharmacel 101 Pharmacel 102 Tablets Capsules Sachets Spheres Direct compression Wet Pharmacel 112 Pharmacel 200 (launch 2019) Superdisintegrants Primojel Primellose Starch Solani Amylum Prejel PA5 PH SuperStarch 200 Dry Product finder on the website To efficiently navigate our portfolio you can use our online product finder by filling in your application and/or product needs and directly order your sample product for delivery. www.dfepharma.com/en/ productfinder.aspx

DFE Pharma sales offices Head Office India Singapore Klever Strasse 187 P.O. Box 20 21 20 47568 Goch Germany T. +49 2823 9288 770 F. +49 2823 9288 7799 pharma@dfepharma.com Plot No. 148 Prestige Featherlite Tech Park 2 nd Phase, EPIP Zone Whitefield, Bangalore 560066 India T. +91 80 4925 6100 F. +91 80 4925 6150 3 Temasek Avenue #11-01 Centennial Tower Singapore 039190 T. +65 6580 8100 F. +65 6580 8191 Japan North America China Kudan Vigas Bldg 3F 1-10-9 Kudan-Kita Chiyoda-Ku Tokyo 102-0073, Japan T. +81 3 5276 7585 F. +81 3 5276 0445 61 South Paramus Road Suite 535 Paramus, NJ 07652 USA T. +1 551 497 7355 F. +1 551 497 7358 Room 302 No. 68 Bohang Road Pudong Shanghai China T. +86 (0)21 6134 5821 F. +86 (0)21 6134 5800 Brazil Rua Fradique Coutinho, 30 - sala 61 05416-000 São Paulo SP Brasil dfepharma.com #001 / September 2018 DMV-Fonterra Excipients GmbH & Co. KG - Warranty The details given here are merely intended for information purposes and are in no way legally binding. Consequently we accept no responsibility in the broadest sense of the word for damage that may result from applications based upon this information. Furthermore, this information does not constitute permission to infringe patent and licence rights.